The company has taken significant steps to enhance operational efficiencies including improvements in sourcing,...
In the Union Budget 2026-27, announcements were made for 7 new bullet train corridors,...
SHL has the capability to manufacture oral liquids, tablets, injectables, dry powder & inhaler...
With robust inflows of c.INR 59bn (ex GST) in 9MFY26, ACIL’s backlog strengthened to...
Ahluwalia enjoys a healthy balance sheet and is a net cash company
The 2 acquired subsidiaries – IAC India and GreenFuel Energy continue to drive growth...
EIL is strategically skewing towards consultancy and cost-plus/OBE turnkey contracts, protecting margins from cost...
We expect Revenue and PAT to grow at 29.8% and 32.8% CAGR over FY25-FY28E.
We anticipate healthy double digit net sales growth and operating margin expansion in near...
DIL’s strong brand recall coupled with deeper penetration and consumers shifting towards affordable branded...